What Is Melanotan II? The Melanocortin Peptide Explained

By Peptide House Research Desk · July 9, 2026 · 6 min read

Illustration of the melanocortin receptors Melanotan II acts on

Melanotan II is a synthetic peptide built to mimic a natural hormone your body already makes. Understanding it means understanding the melanocortin system — a set of receptors that control everything from skin pigment to appetite. This profile covers what the molecule is, the receptors it hits, and an honest read of the research and safety picture.^[1]

What the molecule is

Melanotan II (MT-II) is a cyclic analog of α-melanocyte-stimulating hormone (α-MSH), one of the body's melanocortin hormones. It was developed by researchers at the University of Arizona in the study of skin pigmentation. Compared with natural α-MSH, MT-II is engineered to be more stable and more potent.^[2]

The receptors it acts on

MT-II is described as non-selective, meaning it activates several melanocortin receptors rather than just one. That is central to its research profile:

MC1R — drives melanogenesis, the production of the pigment melanin. This is the pathway behind MT-II's association with skin darkening.
MC4R — involved in appetite and sexual-function signalling. A related MT-II-derived molecule, bremelanotide (PT-141), targets this pathway and reached approval for a specific narrow indication.
MC3R / MC5R — additional melanocortin receptors also engaged by the compound.

MT-II's non-selectivity means it engages multiple melanocortin receptors, which is why its reported effects are broad. Illustrative, Peptide House Research Desk.

Where the evidence — and the cautions — stand

MT-II itself is not an approved drug. A closely related, single-receptor analog (afamelanotide) has been approved for a rare light-sensitivity disorder, but that is a different, more selective molecule. Published literature on MT-II also documents notable side effects — nausea and pigment changes among them — and health authorities in several countries have issued warnings about unregulated products. A responsible profile has to state this plainly: MT-II is a research compound with a real mechanism, a limited formal evidence base, and documented safety concerns.^[3]

Handling in the lab

Melanotan II is supplied lyophilized and handled like other research peptides — cold, dry storage and prompt use after reconstitution (see reconstitution and storage stability). The catalogue listing is on the Melanotan II product page.

For research use only. Not for human or veterinary use. Melanotan II is not an approved product and is associated with documented safety concerns. This article is educational and does not describe or recommend any use in humans and is not medical advice.

References

National Center for Biotechnology Information. "Melanotan II compound summary." PubChem. pubchem.ncbi.nlm.nih.gov.
Dorr RT, Lines R, Levine N, et al. "Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study." Life Sciences, 1996. PubMed.
Habbema L, Halk AB, et al. "Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review." International Journal of Dermatology. PubMed.